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Abstract  22	
During oncogene induced senescence (OIS) heterochromatin is lost from the nuclear periphery and 23	
forms internal senescence associated heterochromatin foci (SAHF). We show that an increased nuclear 24	
pore density during OIS is responsible for SAHF formation. In particular, the nucleoporin TPR is 25	
necessary for both formation and maintenance of SAHF. Loss of SAHF does not affect cell-cycle arrest 26	
but abrogates the senescence associated secretory phenotype – a programme of inflammatory cytokine 27	
gene activation. Our results uncover a previously unknown role of nuclear pores in heterochromatin re-28	
organization in mammalian nuclei and demonstrate the importance of heterochromatin organisation for 29	
a specific gene activation programme.  30	
 31	
Introduction 32	
3D genome organization is governed by a combination of polymer biophysics and biochemical 33	
interactions, including local chromatin compaction, long-range chromatin interactions and interactions 34	
with nucleus structures. One such structure is the nuclear lamina (NL), which coats the inner nuclear 35	
membrane and is composed of lamins and membrane associated proteins, such as LBR. Electron 36	
Boumendil	|	
	
	
2	
2	
microscopy (E.M.) reveals large blocks of heterochromatin associated with the nuclear periphery 37	
(Capelson and Hetzer, 2009), and mapping genome interactions with laminB1 identifies > 1000 lamina-38	
associated domains (LADs). LADs are associated with heterochromatic histone marks (H3K27me3 or 39	
H3K9me3) (Guelen et al., 2008). Altered NL composition in the photoreceptors of nocturnal mammals 40	
leads to the loss of heterochromatin from the nuclear periphery and its accumulation at the centre of the 41	
nucleus (Solovei et al., 2013).  42	
Another situation in which there is a dramatic reorganisation of heterochromatin is in oncogene-induced 43	
senescence (OIS) - a cell cycle arrest program triggered by oncogenic signalling. OIS cells undergo 44	
striking chromatin reorganization, with loss of heterochromatin and constitutive LADs (Lenain et al., 45	
2017) from the nuclear periphery and the appearance of internal senescence-associated 46	
heterochromatin foci (SAHF). SAHF appear consecutive to cell cycle arrest and are not observed in 47	
non-transformed replicating cells (Narita et al. 2003). SAHF formation results from a reorganization of 48	
pre-existing heterochromatin –regions decorated with H3K9me3, H3K27me3, MacroH2a and HP1α,β,γ 49	
- rather than de novo heterochromatin formation on new genomic regions (Narita et al., 2003; Zhang et 50	
al., 2005; Chandra et al., 2012; Sadaie et al., 2013). Known factors implicated in SAHF formation 51	
include; activation of the pRB pathway (Narita et al., 2003), certain chromatin-associated non-histone 52	
proteins (Narita et al., 2006) and the histone chaperones HIRA and Asf1a (Zhang et al., 2005, 2007). 53	
The NL has also been implicated in SAHF formation: LaminB1 and Lamin B receptor (LBR) expression 54	
are decreased in OIS and their experimental depletion can facilitate, but is not sufficient for, SAHF 55	
formation (Sadaie et al., 2013; Lukášová et al., 2017).  56	
The nuclear envelope is perforated by nuclear pores that control transport between the cytoplasm and 57	
nucleus. The nuclear pore complex (NPC) is a large transmembrane complex, consisting of about 30 58	
proteins called nucleoporins (Fig. 1A) (Kim et al., 2018). In contrast to the adjacent NL, E.M. and super-59	
resolution light microscopy show that the nuclear area underneath nuclear pores is devoid of 60	
heterochromatin (Schermelleh et al., 2008; Capelson and Hetzer, 2009) and nuclear pore density in 61	
different neurons and glial cell types from the rat cerebellar cortex anticorrelates with compact chromatin 62	
(Garcia-Segura et al. 1989). The nucleoporin TPR has been shown to be responsible for 63	
heterochromatin exclusion zones at NPCs (Krull et al., 2010).  64	
The composition and density of NPCs changes during differentiation and tumorigenesis (D’Angelo et 65	
al., 2012;; Raices and D’Angelo, 2012; Sellés et al., 2017; Rodriguez-Bravo et al., 2018). We therefore 66	
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hypothesized that NPCs could contribute to global chromatin organization and that, specifically, 67	
heterochromatin organization could result from a balance of forces attracting heterochromatin to the NL 68	
and forces repelling it away from the NPCs (Fig. 1B). In support of this hypothesis, here we show that 69	
nuclear pore density increases during OIS and that this increase is necessary for heterochromatin 70	
reorganization into SAHF. We identify TPR as a key player in this reorganization. Furthermore, we 71	
demonstrate the functional consequences of heterochromatin reorganization in OIS for the programmed 72	
activation of inflammatory cytokine gene expression – the senescence-associated secretory phenotype 73	
(SASP). 74	
 75	
Results and discussion 76	
Nuclear pore density increases during OIS 77	
To assess the role of NPCs in SAHF formation during OIS,  we induced the activity of oncogenic Ras 78	
(RASG12D) by addition of 4-hydroxy-tamoxifen (4HT) in human IMR90 cells, leading to OIS, activation of 79	
p53 and p16 and expression of SASP proteins (Acosta et al., 2013) (Fig. 1C; Fig. S1A). Nuclear pores 80	
disassemble upon entry into mitosis but are very stable during interphase (Daigle et al., 2001; Dultz and 81	
Ellenberg, 2010). In quiescent cells nuclear pore density is stabilised by down-regulation of nucleoporin 82	
mRNAs (D’Angelo et al., 2009). However, expression profiling in OIS cells (ER:Ras) showed that, 83	
compared with control ER:STOP (STOP codon) cells, nucleoporin mRNA levels are unchanged during 84	
senescence (Fig. S1B).  Nucleoporin protein accumulation in senescent cells was confirmed by 85	
immunoblotting for POM121 – an integral membrane protein of the NPC central ring ( Funakoshi et al., 86	
2011) and TPR – a large coiled-coil protein of the nuclear basket (Cordes et al., 1998) (Fig. 1A, D). 87	
Immunofluorescence and structured illuminated microscopy (SIM) (Schermelleh et al., 2008) showed 88	
that increased nucleoporin levels during OIS results in an increased nuclear pore density (Fig. 1E-G). 89	
 90	
Decreasing nuclear pore density leads to loss of SAHF formation 91	
To assess whether the increased nuclear pore density is responsible for heterochromatin reorganization 92	
into SAHF, we used siRNAs to deplete POM121 (Fig. S2A) during the entire course of OIS induction 93	
(Fig. 2A). As expected, since POM121 is required for NPC assembly during interphase (Dultz and 94	
Ellenberg, 2010; Funakoshi et al., 2011), this led to a decrease in nuclear pore density (Fig. 2B, C and 95	
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Fig. S2B). Consistent with our hypothesis, POM121 depletion resulted in a reduction of OIS cells 96	
containing SAHF (Fig. 2D, E). 97	
 98	
The nucleoporin TPR is necessary for SAHF formation and maintenance 99	
TPR is the last nucleoporin to be incorporated in new NPCs (Bodoor et al., 1999) through its interaction 100	
with NUP153 (Hase and Cordes, 2003) (Fig. 1A). TPR has been shown to establish heterochromatin 101	
exclusion zones at nuclear pores (Krull et al. 2010) and to influence HIV integration sites by maintaining 102	
an open chromatin architecture near the NPCs (Lelek et al.. 2015). 103	
To determine if it is the increased abundance of TPR at the nuclear periphery of OIS cells, as a result 104	
of elevated nuclear pore density, that is responsible for SAHF formation, we depleted TPR during OIS 105	
induction (Fig. S3A, B). Contrary to a recent report, TPR depletion did not affect nuclear pore density 106	
(McCloskey et al., 2018) (Fig. S3C). However similar to POM121 depletion, TPR depletion led to the 107	
loss of SAHF (Fig. 3A, B).  We confirmed these results with four independent siRNAs targeting TPR 108	
(Fig. S3D-F). We conclude that TPR is necessary for the formation of SAHF during OIS.  109	
The effect of TPR knockdown on heterochromatin re-localization during OIS does not appear to be due 110	
to obvious changes in the amount of laminB1 at the nuclear lamina, (Fig S4A). 111	
To assess whether TPR is necessary for maintenance as well as the formation of SAHF, we used a time 112	
course to determine when SAHF are formed. The percentage of cells containing SAHF increased 113	
gradually after 4HT treatment of ER:Ras cells, reaching a maximum at 6 days (Fig. S4B). We therefore 114	
depleted TPR 6 days after 4HT addition, when SAHF have already formed (Fig. 3C). We observed a 115	
dramatic reduction of cells containing SAHF two days later (day 8) (Fig. 3D, E). siRNA depletion under 116	
these conditions was only partial and we observed loss of SAHF in cells specifically depleted for TPR, 117	
whereas SAHF were maintained in cells where knockdown was incomplete (Fig. S4C). In some cells 118	
with partial TPR depletion, there was a relocalization of heterochromatin to the nuclear periphery in 119	
patches that correspond to sites of TPR-depletion (Fig. 3F),  but that still contained nuclear pores as 120	
detected by MAB414 staining (Fig 3G). We conclude that exclusion of heterochromatin from the nuclear 121	
periphery by TPR is necessary for both the formation and maintenance of SAHF during OIS.  122	
 123	
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TPR is necessary for the senescence-associated secretory phenotype  124	
SAHF are proposed to be involved in silencing pro-mitotic genes, contributing to stable cell cycle arrest 125	
(Narita et al., 2003; Narita et al., 2006; Zhang et al., 2007). However, TPR- depleted OIS cells did not 126	
show defective cell-cycle arrest as assayed by BrdU incorporation and activation of p16, p21 and p53 127	
(Fig. S5A-C). This suggests that SAHF are dispensable for cell-cycle arrest, in agreement with the fact 128	
that not all senescent cells form SAHF (Kosar et al., 2011). Furthermore SAHF have been shown to be 129	
insufficient to maintain cell cycle arrest as inactivation of p53 or ATM in OIS cells leads to senescence 130	
escape without SAHF alteration (Di Micco et al., 2011).   131	
An important characteristic of OIS is activation of the senescence associated secretory phenotype 132	
(SASP) which is responsible for the non–cell autonomous effects of senescence. SASP consists of the 133	
expression and secretion of cytokines, chemokines, extracellular matrix proteases, growth factors and 134	
other signalling molecules. SASP is a tumour suppressive mechanism which reinforces cell cycle arrest 135	
and leads to paracrine senescence but can also promote tumour progression in premalignant lesions 136	
(Coppé et al., 2010; Acosta et al., 2013). Strikingly, in the absence of SAHF after TPR depletion, we 137	
observed a complete loss of the SASP as exemplified by lack of IL1α, IL1β, IL6 and IL8 mRNA and 138	
protein (Fig 4A-C, Fig. S5D, E). SAHF and SASP loss upon TPR depletion does not seem to be due to 139	
a general defect in nuclear transport as we detected NFκB nuclear import upon induction of paracrine 140	
senescence (Acosta et al., 2008; Chien et al., 2011; Acosta et al., 2013) (Fig. S6A- C). 141	
Similarly to some other nucleoporins, a fraction of TPR is present in the nucleoplasm as well as at 142	
nuclear pores (Frosst et al., 2002). To assess whether it is the increase in nuclear pore density in OIS 143	
– and consequent increased TPR abundance at the nuclear periphery - that is necessary for SASP or 144	
whether TPR has an independent role, we assessed SASP upon depletion of POM121 which is only 145	
present within the NPC. Decreased nuclear pore density upon POM121 depletion did not affect cell-146	
cycle arrest (Fig. S7A), but the SASP was impaired (Fig. S7B-D).  147	
The nuclear pore basket nucleoporin NUP153 (Fig. 1A) is necessary for the association of TPR with the 148	
NPC (Hase and Cordes 2003). To further confirm that the role of TPR in SAHF formation and SASP 149	
depends on its presence at the NPC rather than in the nucleoplasm, we depleted NUP153 (Fig. S8A), 150	
NPC density was unchanged (Fig. S8B), but consistent with the role of NUP153 in TPR-nuclear basket 151	
association, TPR-containing NPC density decreased upon NUP153 depletion (Fig. S8C). 152	
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Concomitantly, the percentage of SAHF containing cells decreased (Fig. S8D, E) and the SASP was 153	
lost (Fig. S8F). We conclude that it is TPR association with NPC that is necessary for SAHF formation 154	
and SASP activation in OIS. 155	
 156	
Chromatin reorganization controls the SASP 157	
Our results suggest that heterochromatin reorganization is necessary for SASP during OIS. To exclude 158	
that nuclear pores regulate SASP through another independent mechanism, we used a different means 159	
to deplete SAHF. The histone chaperone ASF1a is required for SAHF formation (Zhang et al., 2005, 160	
2007) and indeed its depletion led to a loss of SAHF in ER-Ras cells (Fig. 5A-C). ASF1a depletion did 161	
not affect nuclear pore density (Fig. 5D), but as for TPR and POM121 depletion, there is a dramatic loss 162	
of the SASP upon ASF1a depletion in ER-Ras cells (Fig. 5E).  Whilst we cannot completely rule out that 163	
intact nuclear pores are needed for SASP activation independent of chromatin reorganization, this result 164	
supports the hypothesis that heterochromatin reorganization is necessary for the SASP.  165	
Our data suggest that an increase in nuclear pore density is responsible for the eviction of 166	
heterochromatin from the nuclear periphery by TPR and the consequent formation of SAHF in OIS. 167	
Similar mechanisms could be conserved in other types of senescence as nuclear pore density is also 168	
increased in replicative senescence (Maeshima et al. 2006). Chromatin organisation relative to the 169	
nuclear periphery has generally been considered from the point of view of interactions between 170	
(hetero)chromatin and components of the nuclear lamina. Here we demonstrate that the repulsion of 171	
heterochromatin by nuclear pores is another important principle of nuclear organisation and it will be 172	
interesting to establish whether the modulation of nuclear pore density also influences the 3D 173	
organisation of the genome during development. 174	
Methods  175	
Cell culture  176	
IMR90 cells were infected with pLNC-ER:RAS and pLXS-ER:Stop retroviral vectors to produce ER-RAS 177	
and ER-Stop cells respectively (Acosta et al., 2013). Ras translocation to the nucleus was induced by 178	
addition of 4-hydroxy-tamoxifen (4HT) (Sigma) diluted in DMSO to 100 nM. 4HT containing-medium 179	
was changed every 3 days. 180	
 181	
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SiRNA transfection 182	
2x105 IMR90, ER-STOP and ER-Ras cells were transfected using Dharmafect transfection reagent 183	
(Dharmacon) with a 30 nM final concentration of predesigned siRNAs (Dharmacon, Table S1). 184	
 185	
RNA expression analysis 186	
mRNA expression profiling was by IonTorrent mRNA sequencing using the Ion AmpliSeq™ 187	
Transcriptome Human Gene Expression Kit. 6 biological replicates were analysed and adjusted p-value 188	
were calculated by Benjamini and Hochberg (BH) and FDR multiple test correction. Data analysis was 189	
performed using Babelomics-5 (http://babelomics.bioinfo.cipf.es).  190	
For individual mRNAs, total RNA was extracted using the RNeasy minikit (QIAGEN) and cDNAs 191	
generated using Superscript II (Life technologies). Real-time PCR ws performed on a Lightcycler 480 192	
(Roche) using SYBR Green PCR Master Mix (Roche) using primer listed in Table S3. Expression was 193	
normalized to β-actin.  194	
 195	
Immunoblotting 196	
1x106 cells were lysed in RIPA buffer and protein concentration determined using a Pierce BCA protein 197	
analysis kit. 15 µg of proteins were run into NuPage 3-8% Tris acetate gels (Invitrogen). After transfer 198	
onto nitrocellulose with a iBlot 2 gel transfer device (Thermofisher), immunoblotting was done using 199	
antibodies as listed in Table S2. 200	
 201	
Immunofluorescence and SAHF measurement 202	
2x105 cells were seeded and grown on coverslips during senescence induction. Cells were fixed in 4% 203	
paraformaldehyde (pFa) for 10 min at room temperature, permeabilized in 0.1% Triton X100 for 10 min, 204	
blocked in 1% BSA for 30 min, incubated with primary antibodies diluted in 1% BSA for 1h and with 205	
fluorescently labelled secondary antibodies (Life Technologies) for 45 min. Coverslips were 206	
counterstained with DAPI and mounted in Vectashield (Vectorlabs). 207	
To detect replicating cells, cells were incubated with 10 µM 5-Bromo-2’ – deoxyuridine (BrdU) (Sigma) 208	
for 16 h prior to fixation and immunodetection using a BrdU antibody (BD Pharmingene 555627) in the 209	
presence of 1 mM MgCl2 and 0.5 U/ul DNaseI (Sigma D4527). 210	
Detection of SASP proteins, tumour suppressors and BrdU positive cells by high content microscopy is 211	
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described at (Hari and Acosta 2017). The % SAHF positive cells was determined by manual examination 212	
of 100-200 DAPI stained cells.  213	
 214	
Structured Illumination Microscopy (SIM) and measurement of nuclear pores density 215	
The bottom plane of cells was imaged by 3D SIM (Nikon N-SIM) and reconstructed using NIS element 216	
software after immunofluorescence with antibodies as indicated in Table S2. 15 nuclei were imaged for 217	
each condition and 5 ROI of 100x100 pixels were analyzed/nucleus. Individual nuclear pore complexes 218	
in each ROI were counted manually.  219	
 220	
β-Galactosidase staining 221	
SA-β-Gal staining solution was prepared using 20x KC(100 mM K3FE (CN)6 and 100 mM K4Fe (CN) 222	
6*3H2O in PBS), 20x X-Gal solution (ThermoFisher Scientific) diluted to 1x in PBS/1 mM MgCl2 at pH 223	
5.5-6. Staining was conducted overnight on glutaraldehyde fixed cells. 224	
 225	
Statistics 226	
All experiments were performed in a minimum of 3 biological replicates. Error bars are standard error 227	
of the mean. P-values were obtained by two sample equal variance, 2 tails t-test.  228	
 229	
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Figure Legends 336	
Figure 1. Nuclear pore density increases in OIS 337	
A) Model of the nuclear pore complex showing the position of TPR, NUP153 and POM121. Adapted 338	
from (Hoelz et al. 2011). 339	
B) Schematic showing the balance of forces attracting heterochromatin to the nuclear lamina and 340	
repelling heterochromatin from nuclear pores. 341	
C) Schematic of OIS induction in ER:Ras cells by 4HT and continued proliferation in ER:Stop cells. 342	
D) Western blot showing POM121 (left panel) and TPR (right panel) levels in 4HT treated ER:Stop and 343	
ER:Ras cells. 344	
E) TPR immunostaining in ER:STOP and ER:Ras cells treated with 4HT. Left: bottom plane of nucleus 345	
imaged by SIM. Right: enlargement of the insets. Scale bars  2µm. 346	
F) Mean (+/- SEM) nuclear pore density (pores/µm2) in 4HT treated ER:Stop and ER:Ras cells as 347	
counted by TPR staining in 3 biological replicates, ***p=0.0001. 348	
G) As for F) but for Pom121 staining. h.s = highly significant p=1.3E-06. 349	
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Figure 2. Increased nuclear pore density in OIS is necessary for SAHF formation 351	
A) Schematic showing depletion experiment for panels B to E. 352	
B) MAB414 (antibody recognizing several nucleoporins) immunostaining in ER:STOP cells treated with 353	
4HT after 2 days knockdown with scramble (Scr) or POM121 siRNAs. Left: bottom plane of nucleus 354	
imaged by SIM.  Right: enlargement of the insets. Scale bars 2µm. 355	
C) Mean (+/- SEM) nuclear pore density (pores/µm2) in 4HT treated ER:Stop cells after scramble (Scr) 356	
or POM121 siRNA knockdown, as assayed by TPR staining in 3 biological replicates, * p<0.05. 357	
D) DAPI staining of 4HT-treated ER:Stop and ER:Ras cells in controls (Scr) and upon POM121 depletion 358	
(siPOM121). Scale bars 10µm. Bottom: enlargement of the insets. 359	
E) Mean (+/- SEM) % of cells containing SAHF in 4HT-treated ER:Stop and ER:Ras cells after 360	
knockdown with scramble (Scr) siRNAs and in 4HT-treated ER:Ras cells with POM121 siRNAs. Data 361	
from 3 experiments. *p<0.05, h.s=highly significant. 362	
 363	
Figure 3. TPR is necessary for SAHF formation and maintenance 364	
A) DAPI staining of non-senescent 4HT treated ER:Stop and OIS (ER:Ras) cells after control scramble 365	
(Scr) siRNA and upon TPR depletion (siTPR). Scale bars 10µm. 366	
B) Mean (+/- SEM) % of cells containing SAHF in 4HT-treated ER:Stop and ER:Ras cells after 367	
knockdown siRNAs as in (A). Data from 3 experiments. **p<0.01, h.s=highly significant. 368	
C) Time course for TPR depletion by siRNA late in the OIS programme as performed for panels D-F. 369	
D) DAPI staining of 4HT-treated ER:STOP and OIS cells ER:Ras in controls (Scr) and upon TPR 370	
depletion (siTPR). Scale bars 2µm. 371	
E) Mean (+/- SEM) % of cells containing SAHF in 4HT-treated ER:Stop and ER:Ras cells after 372	
knockdown with scramble (Scr) siRNAs and in ER:Ras cells with TPR siRNAs. Data from 3 experiments. 373	
**p<0.01, h.s=highly significant. 374	
F) DAPI (blue) and TPR (red) staining of 4HT-treated ER:STOP and ER:Ras upon TPR depletion 375	
(siTPR) imaged by SIM. Right: enlargement of the insets. Scale bars 2µm. 376	
G) DAPI (blue) and TPR (red) staining of 4HT-treated ER:Ras cells upon TPR depletion (top). Bottom 377	
image shows co-staining with the nucleoporin antibody MAB414 (green). 378	
 379	
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Figure 4. TPR is necessary for the SASP 380	
A) Mean (± SEM) mRNA level, measured by qRT-PCR for SASP genes (IL1α, IL1β, IL6,I L8), in 4HT-381	
treated ER:Stop and ER:Ras cells after knockdown with scramble (Scr) siRNAs and in 4HT-treated 382	
ER:Ras cells with TPR siRNAs. Expression is relative to ER:Ras cells transfected with Scr siRNAs. Data 383	
from 3 experiments. h.s=highly significant. 384	
B) Mean (± SEM) % of cells positive by immunostaining for SASP cytokines (IL1α, IL1β, IL6,IL8) in 385	
4HT-treated ER:Stop and ER:Ras cells after SiRNA knockdown as in (A). Data from 3 experiments. 386	
**p<0.01, *** p<0.001,  h.s=highly significant. 387	
C) Immunostaining (green) for IL1α  and IL1β  in DAPI (blue) stained nuclei of 4HT-treated ER:Stop 388	
and ER:Ras cells subjected to RNAi as in (A). Scale bars 100µm. 389	
 390	
Figure 5. Chromatin reorganization seems necessary for the SASP 391	
A) Mean (± SEM) ASF1a mRNA level, established by qRT-PCR, in 4HT-treated ER:STOP and ER:Ras 392	
cells after knockdown with scramble (Scr) or ASF1a siRNAs. Expression is shown relative to ER:STOP 393	
cells transfected with Scr siRNAs. Data from 3 experiments. *p<0.05. 394	
B) DAPI staining of 4HT-treated ER:STOP and ER:Ras cells in controls (Scr) and upon ASF1a depletion 395	
(siASF1a). Scale bars 2µm 396	
C) Mean (+/- SEM) % of cells containing SAHF in 4HT-treated ER:Stop and ER:Ras cells after 397	
knockdown with scramble (Scr) siRNAs and in ER:Ras cells with ASF1a SiRNAs. Data from 3 398	
experiments. ***p<0.001.  399	
D) Mean (+/- SEM) nuclear pore density (pores/µm2) in 4HT treated ER:Stop cells after knock down with 400	
scramble (Scr) or ASF1a (siASF1a) siRNAs as counted by MAB414 or TPR staining in 3 biological 401	
replicates, n.s= non significant. 402	
E) Mean (± SEM) mRNA levels, measured by qRT-PCR for IL1α, IL1β, IL6, IL8, in 4HT-treated ER:Stop 403	
and ER:Ras cells after knockdown with scramble (Scr) siRNAs and in 4HT-treated ER:Ras cells with 404	
ASF1a siRNAs. Expression is shown relative to ER:Ras cells transfected with Scr siRNAs. Data from 3 405	
experiments. ***p<0.001, h.s=highly significant. 406	
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